Hypertension in the lungs is a relatively rare but very serious disease that is usually fatal within two years if left ...
News Medical on MSN
Beta arrestin 1 emerges as key driver of pulmonary hypertension
Researchers have uncovered the pivotal role of a previously overlooked protein in the development of the serious illness.
As the world marks Rare Disease Month, health experts are urging greater awareness of conditions that often go unnoticed ...
PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary ...
Can a one-minute sit-to-stand test predict long-term outcomes in pulmonary hypertension? New data suggest it can. Read more.
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
A 38-year-old male patient was admitted to Father Muller Medical College and Hospital (FMMCH) after being diagnosed with right lower limb deep vein thrombosis (DVT). He had a history of breathlessness ...
Significant predictors of 28-day mortality in critically ill patients with systemic sclerosis include male sex and BMI.
There seems to be a causal relationship between genetic susceptibility to idiopathic pulmonary fibrosis (IPF) and hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results